Recent data [Lopez-Farre, Riesco, Moliz, Egido, Casado, Hernando and Caramelo (1991) Biochem. Biophys. Res. Commun. 178,[884][885][886][887][888][889][890][891] revealed that endothelin 1 (ET-1) increases intracellular free [Ca2"] in polymorphonuclear leucocytes (PMN) by a mechanism that can be inhibited by L-arginine. The aim of the present study was to clarify the mechanisms of the interaction between the effects of ET-1 and Larginine in human PMN. The experimental findings showed that in human PMN: (a) ET-1 and the chemoattractant peptide Nformylmethionyl-leucyl-phenylalanine (fMLP) induce both the metabolism of L-arginine to L-citrulline and cyclic GMP (cGMP) formation; (b) the ET-I -induced cGMP production is inhibitable by the L-arginine antagonist NG-monomethyl-L-arginine, there-
INTRODUCTION
Endothelin-1 (ET-1) is a potent vasoconstrictor peptide synthesized by endothelial cells, which is highly expressed in several pathological circumstances, namely myocardial or renal ischaemia and cyclosporin toxicity [1] [2] [3] . Several studies have shown that ET-1 represents a constricting signal from the endothelium to contractile cells [4, 5] . However, some reports have further suggested that ET-1 may also act on the blood cells [6] . Recently, studies from several laboratories, including ours, have found a significant effect of ET-1 on human polymorphonuclear leucocytes (PMN), either by increasing mobilization of intracellular Ca2l in PMN [7] , N-formylmethionyl-leucyl-phenylalanine (fMLP)-mediated superoxide anion production [8] and aggregation [9] .
PMN are able to produce NO from L-arginine [10] [11] [12] [13] [14] and subsequently to increase cyclic GMP (cGMP) production via the soluble guanylate cyclase [15] . cGMP has been regarded as a physiological antagonist of Ca2l-mediated mechanisms in different types of cells , including macrophages [19, 20] and platelets [21] . However, the role of NO/cGMP in monocytes/macrophages [22, 23] and PMN [24] is still insufficiently substantiated. In fact, the properties of NO/cGMP on these types of cells include stimulation of chemotaxis [23, 24] , production of tumour necrosis factor-a [23] and vimentin phosphorylation [25] , but also NO/cGMP-mediated blockade of ET-1-or fMLP-induced [Ca2"], transients [7] . Therefore the NO/cGMP-mediated mechanisms in leucocytes are probably of a more complex nature than initially suspected.
We previously reported that L-arginine-mediated NO production acts as a negative-feedback mechanism on the PMN fore suggesting the involvement of NO; (c) the ET-1-or fMLPinduced NO/cGMP stimulation is critically dependent on the availability of L-arginine; (d) human PMN possess a L-arginine transport system with both Na+-dependent and -independent components; (e) the L-arginine transport system in PMN appears to be feedback-regulated by NO/cGMP in ET-1-stimulated conditions, but not under baseline conditions; (f) the L-arginine transport system in PMN is independent of the y-glutamyl cycle and is not modified by either ET-1 or fMLP. The L-arginine/ NO/cGMP-dependent mechanisms characterized in the present study may be relevant in the regulation of PMN activation in pathophysiological conditions in vivo.
activation [7] . However, the actual importance of the NOdependent cGMP generation on PMN activation has not yet been established. In this regard, an interaction between ET-I and the NO/cGMP-mediated mechanisms is probably of biological relevance.
The aim of the present study was to examine the mechanisms of the interaction between ET-1 and L-arginine/NO/cGMP in human PMN. These interactions were analysed at different levels: (a) the influence of ET-1 on cGMP production; (b) the effect of ET-1 on the metabolism of L-arginine to citrulline; (c) the mechanisms of L-arginine uptake in PMN and the effect of ET-l on L-arginine uptake, including the feedback regulation of stimulated and unstimulated L-arginine uptake by NO/cGMPdependent mechanisms. To evaluate further the characteristics and intensity of the response to ET-1, the well-known chemoattractant peptide fMLP was used as an additional PMN activator in several of the experiments.
MATERIALS AND METHODS Chemicals
Ficoll/Hypaque medium was obtained from Flow Laboratories. Fura-2 acetoxymethyl ester (Fura-2/AM) was Measurement of cGMP cGMP concentrations were measured as described previously [28] in acetylated samples, by means of an iodinated radioimmunoassay kit (Amersham). In brief, PMN were preincubated in the presence or absence of L-arginine (0.1 mM) for 60 min at 37 'C. After washing twice, PMN were incubated (1 min, 37 'C) in PSS-Ca2+ containing the phosphodiesterase inhibitor 3-isobutyl-l-methylxanthine (IBMX; 2 mM). IBMX was used in the experiments concerning cGMP to avoid any possible interference by changes in phosphodiesterase activity and to facilitate the accumulation of cGMP. fMLP (0.1 ,uM), ET-1 (0.1 1M) or SNP) (10,c1M) was then added and the incubation continued for a further 2 min. In similar samples, L-arginine was co-incubated with the L-arginine antagonist L-NMMA (0.5 mM), or the soluble guanylate cyclase blocker Methylene Blue (MB; 10 ,M) [29, 30] 
RESULTS
Ca2+ mobilization by ET-1 and fMLP As previously described [7] , ET-1 and fMLP provoked a (Table 1 ). This effect was reversed by co-incubation with the L-arginine antagonist L-NMMA (0.5 mM) ( Table 1 ; [7] ) and in the presence of the inhibitor of the soluble guanylate cyclase MB (10 uM), therefore suggesting that the effect of L-arginine is dependent on the activity of the NO synthase and the subsequent cGMP formation. This effect of Larginine was stereospecific, since no inhibition was observed with 0.1 mM D-Arg (n = 3). To confirm more directly the role of cGMP as a regulator of the ET-1-or fMLP-induced [Ca2+]1, PMN were preincubated (10 min) in the presence of 0.1 mM 8- [Ca2+] ( Effect of ET-1 or fMLP on cGMP levels As shown in Table 2 , ET-1 (0.1 uM) did not affect baseline cGMP in PMN. However, cGMP significantly increased when ET-1 or fMLP was added to L-arginine-preincubated PMN (Table 2) . Preincubation with L-arginine increased cGMP content in unstimulated PMN, albeit in a smaller proportion (Table 2) . In L-arginine-preincubated PMN, the ET-1-mediated cGMP increase was inhibited by co-incubation with the L-arginine antagonist L-NMMA (0.5 mM) and by the inhibitor of soluble guanylate cyclase, MB (10 ,M), therefore suggesting a critical role of the NO synthase/guanylate cyclase sequence. The cGMP increase induced by 10 uM SNP was not modified by the coincubation with ET-1 or L-arginine, therefore ruling out any direct influence on the activity of guanylate cyclase itself (Table  2) . Similarly to ET-1, fMLP provoked a significant (P < 0. Since the activity of the constitutive NO synthase appears to be dependent on calmodulin-bound Ca2+ [12, 13] , and in previous experiments [7] On the basis of the above results, the next series of experiments was carried out to examine whether ET-1 or fMLP would increase NO synthase activity by stimulating the cellular uptake of its substrate, L-arginine. L-Arginine transport In PMN First, we characterized the L-arginine transport system in PMN. In the presence of 100 ,tM extracellular L-arginine, the L-arginine uptake was linear for approx. 30 Figure 2(b) , both a Na+-dependent and a Na+-independent component of the L-arginine influx were identified. In Na+-free medium (Figure 2b ), the Vmax decreased (Vmax 0.059 + 0.01 ,umol/min per mg of protein; P < 0.05 with respect to Na+-containing medium) without changes in the Km (1635 + 200 uM; not significant with respect to Na+-containing medium).
Furthermore, the implication of the y-glutamyl cycle in the transport of L-arginine into PMN was examined. PMN were preincubated (15 min and 4 h) in the presence of 0.1 mM BSO, an irreversible inhibitor of y-glutamylcysteine synthetase [33] . BSO did not modify the L-arginine uptake by PMN (baseline 0.13 + 0.03, BSO 15 min 0.12 +0.09, BSO 4 h 0.14 +0.05 ,tmol/ mg of protein).
Under the above-mentioned conditions, ET-1 (0.1 ,uM) did not change either the Na+-dependent (results not shown) or the Na+-independent L-arginine uptake by PMN (Table 3 ). This result suggested that the observed increase in cGMP production by ET-1 did not involve an increased L-arginine uptake. However, the possibility needed to be raised that a feedback regulation of the L-arginine uptake by the end-product of the pathway, i.e. cGMP, might exist.
To study whether a product-dependent feedback was operative in regulating L-Arg uptake, PMN were preincubated in the presence of 8-Br-cGMP (0.1 mM, 10 (not significant with respect to baseline). However, when similar experiments were done in the presence of ET-1, significantly lower K, values were found, therefore indicating that ET-l actually increased the affinity of the L-arginine uptake system in the presence of NO synthase inhibition (Table 3) . No variations in Vmax were detected (Table 3) . This effect by ET-1, in the presence of L-NMMA, was no longer observed when the PMN were preincubated in the presence of 8-Br-cGMP (10 min, 0.1 mM).
MetabWism of L-[3H]arginine
To determine whether exogenous L-(3H]arginine is used in a pathway leading to NO formation in PMN, we studied the PMN produce NO from L-arginine [10] [11] [12] [13] [14] 24] , a process that is enhanced by fMLP [10] . In the present study, we have hypothesized that NO may have an autocrine role in PMN. This hypothesis was supported by the evidence that the [Ca2+]i transients were blocked in the presence of L-arginine or 8-BrcGMP, and by the ET-1-or fMLP-induced elevation of intracellular cGMP levels in L-arginine-incubated PMN. On the contrary, only a small effect of extracellular Ca2+ was found on the ET-l-stimulated cGMP generation. In previous experiments we have seen that the ET-l-induced [Ca2+]i peak was abolished in the presence of Ca2+-free EGTA buffer. Therefore, this latter result is consonant with reports suggesting that the predominant NO synthase isoenzyme in PMN is independent of calmodulinbound Ca2+ [12, 13] .
The L-arginine dependence of the cGMP increase and the reversal of the L-arginine effect by L-NMMA both suggested that the effect of ET-1 and fMLP is NO-dependent. Furthermore, the inhibition of this effect by MB demonstrated the implication of the soluble guanylate cyclase. More direct evidence for the presence of this mechanism was obtained in the experiments showing an increased L-citrulline generation in L-argininepreloaded PMN after stimulation with either ET-1 or fMLP. Although PMN may metabolize L-arginine by arginase [20, 34, 35] , the inhibition of L-citrulline generation by the NO-donor antagonist L-NMMA ruled out the involvement of arginase in the L-arginine conversion into L-citrulline. Additional studies are needed to determine the precise mechanism of NO synthase stimulation by ET-1 and fMLP.
The intracellular concentration of L-arginine appears to be a significant factor for NO synthesis in PMN, as judged by the present series of experiments and as reported by other authors for endothelial cells in L-arginine-deficient conditions [36] . PMN probably became depleted of L-arginine during the isolation procedure, and incubation in the presence of exogenous Larginine restores the intracellular L-arginine pool. Different authors have reported the importance of local L-arginine levels in macrophage function [19, 20] , and the present results are further suggestive that changes in L-arginine availability may induce profound changes in PMN biology. From the above results, the existence of a mechanism stimulating L-arginine uptake by ET-1 or fMLP, and coupled to NO formation, was a possibility to be considered. As shown in this study, human PMN transport Larginine by both Na+-dependent and Na+-independent transport systems. Cationic or basic amino acids as L-arginine are transported in several cells by a selective carrier, namely system y+, or similar [37] . System y+ is generally Na+-independent, but in some cases, as in renal and intestinal brush-border membranes, it may be partially Na+-dependent [37] . Adaptive responses of amino acid uptake have been demonstrated in cells of mesenchymal origin [38] . Transport systems for diverse amino acids have been characterized in blood cells akin to PMN, namely myeloid leukaemia cells and macrophages [39, 40] . A different distribution of Na+-dependent and -independent systems has been observed, depending on the particular type of amino acids [39, 40] , but no specific results on L-arginine uptake by PMN have been reported so far. The fact that the interference with the y-glutamyl system by BSO did not affect the rate of Larginine uptake supports the presence of a y+-type system for L-arginine transport in PMN. A similar transport system has been reported for L-lysine in macrophages [41, 42] .
The effects of ET-1 and NO/cGMP on the L-arginine transport system in human PMN appeared to interact in a feedback mechanism. The findings that the stimulation of Larginine uptake by ET-1 is evident only in the presence of the L-arginine antagonist L-NMMA, and that this effect of the L-arginine antagonist is reversed by the cGMP analogue 8-Br-cGMP, both suggest that the putative L-arginine transport system is activated by ET-1 and feedback-inhibited by cGMP. The elucidation of the precise mechanisms of these effects requires further clarification of the characteristics and regulatory sites of the L-arginine transport system. 
